Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137436
Status:
COMPLETED
Last Update Posted:
2011-08-29
First Post:
2005-08-26
Brief Title:
Study Of SU011248 In Combination With Docetaxel Taxotere And Prednisone In Patients With Prostate Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostatic Neoplasms |
Keywords:
| Name | View |
|---|---|
| First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone | View |